CFDE Data Portal | Search EYA2

	Label	Description
	EYA2 Gene (Entity type)	ENSG00000064655 - EYA transcriptional coactivator and phosphatase 2
	GSE230865 EYA2 knockdown 3 v 2 human dn Gene Set (Entity type)	A Gene Set from LINCS
	EYA2 associations Collection (Entity type)	Associations for EYA2_associations
	GSE230865 EYA2 knockdown 3 v 4 human up Gene Set (Entity type)	A Gene Set from LINCS
	GSE230865 EYA2 knockdown 3 v 2 human up Gene Set (Entity type)	A Gene Set from LINCS
	EYA2 associations.tsv File (Entity type)	A file from IDG as part of the Harmonizome project
	EYA2-AS1 Gene (Entity type)	ENSG00000236028 - EYA2 antisense RNA 1
	GSE230865 EYA2 knockdown 3 v 4 human dn Gene Set (Entity type)	A Gene Set from LINCS
	GSE102505 5 V 0 TUNICAMYCIN HUMAN DN Gene Set (Entity type)	A Gene Set from LINCS
	GSE226249 pirfenidone HL 2 v 1 human up Gene Set (Entity type)	A Gene Set from LINCS

EYA2

ENSG00000064655 - EYA transcriptional coactivator and phosphatase 2

GSE230865 EYA2 knockdown 3 v 2 human dn

A Gene Set from LINCS

EYA2 associations

Associations for EYA2_associations

GSE230865 EYA2 knockdown 3 v 4 human up

A Gene Set from LINCS

GSE230865 EYA2 knockdown 3 v 2 human up

A Gene Set from LINCS

EYA2 associations.tsv

A file from IDG as part of the Harmonizome project

EYA2-AS1

ENSG00000236028 - EYA2 antisense RNA 1

GSE230865 EYA2 knockdown 3 v 4 human dn

A Gene Set from LINCS

GSE102505 5 V 0 TUNICAMYCIN HUMAN DN

A Gene Set from LINCS

GSE226249 pirfenidone HL 2 v 1 human up

A Gene Set from LINCS

DISPLAY PER PAGE

@CFDE Workbench 2026

The CFDE Workbench is actively being developed and maintained by the CFDE Data Resource Center (DRC).The DRC is funded by OT2OD036435 from the Common Fund at the National Institutes of Health.

The CFDE Workbench is actively being developed and maintained by the CFDE Data Resource Center (DRC).The DRC is funded by OT2OD036435 from the Common Fund at the National Institutes of Health.

@CFDE Workbench 2026

This repository is under review for potential modification in compliance with Administration directives.